Journal
ACTA NEUROPATHOLOGICA COMMUNICATIONS
Volume 3, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s40478-015-0220-4
Keywords
Alzheimer's disease; Tau pathology; THK5117; Imaging biomarker; Autopsy brain; Autoradiography
Categories
Funding
- Swedish Research Council [05817]
- Swedish Brain Power
- Regional Agreement on Medical Training and Clinical Research (ALF) for Stockholm County Council
- Strategic Research Programme in Neuroscience at Karolinska Institutet
- Foundation for Old Servants
- Gun and Bertil Stohnes Foundation
- KI Foundations
- Swedish Brain Foundation
- Swedish Alzheimer's Foundation (Alzheimerfonden)
- Demensfonden
- Wenner-Gren Foundation
- Foundation of Sigurd and Elsa Golje's memory
- EU FW7 large-scale integrating project INMiND
- Swedish Foundation for Strategic Research (SSF)
- US Grant [P30 AG010133]
- Grants-in-Aid for Scientific Research [26117003] Funding Source: KAKEN
Ask authors/readers for more resources
Introduction: The accumulation of neurofibrillary tangles, composed of aggregated hyperphosphorylated tau protein, starts spreading early in specific regions in the course of Alzheimer's disease (AD), correlating with the progression of memory dysfunction. The non-invasive imaging of tau could therefore facilitate the early diagnosis of AD, differentiate it from other dementing disorders and allow evaluation of tau immunization therapy outcomes. In this study we characterized the in vitro binding properties of THK5117, a tentative radiotracer for positron emission tomography (PET) imaging of tau brain deposits. Results: Saturation and competition binding studies of H-3-THK5117 in post-mortem AD brain tissue showed the presence of multiple binding sites. THK5117 binding was significantly higher in hippocampal (p < 0.001) and temporal (p < 0.01) tissue homogenates in AD compared to controls. Autoradiography studies with H-3-THK5117 was performed on large frozen brain sections from three AD cases who had been followed clinically and earlier undergone in vivo F-18-FDG PET investigations. The three AD cases showed distinct differences in regional THK5117 binding that were also observed in tau immunohistopathology as well as in clinical presentation. A negative correlation between in vivo F-18-FDG PET and in vitro H-3-THK5117 autoradiography was observed in two of the three AD cases. Conclusions: This study supports that new tau PET tracers will provide further understanding on the role of tau pathology in the diversity of the clinical presentation in AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available